BridgeBio Pharma, Inc. FY2025 benchmark
Not classified · Not classified. Only figures matched to an original company report are shown.
Sourced figures
- Revenue · BridgeBio Pharma, Inc. FY2025 — SEC XBRL company filing
- $502.1mSource
Not classified · Not classified. Only figures matched to an original company report are shown.